


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
AZN
Astrazeneca
$200.73
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Expands stock buyback program
AZN Price Performance
$197.52 (+1.63%)
$94.96 (+111.38%)
$83.77 (+139.62%)
$67.05 (+199.37%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue increase YoY
Earnings decline YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Expands stock buyback program
Future
Future
Earnings are forecast to grow
AZN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AZN Street Sentiment is extremely bullish and have positive views on the near-term outlook
AZN has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 03, 2026
Upgrade
Hold
Jan 29, 2026
Initiate
Buy
Citigroup
Dec 06, 2025
Reiterate
Overweight
JP Morgan
Nov 12, 2025
Reiterate
Buy
Jefferies
Nov 12, 2025
Reiterate
Overweight
JP Morgan
PFE
Pfizer
28.55
+1.67%
TEVA
Teva Pharma
30.25
+0.43%
NVS
Novartis AG
155.08
+1.53%
MRK
Merck Company
120.84
+0.44%
HCM
HUTCHMED (China) Limited
15.14
+1.20%
What is AZN current stock price?
What are AZN stock strengths?
What is AZN Risk Level?
What is AZN market cap and volume?
What is AZN current Stock IQ?
Should I buy AZN stock right now?
Is AZN a Strong Buy right now?
What does a 'Strong Buy' rating mean for AZN?
What does a 'Strong Sell' rating mean for AZN?
What factors influence AZN's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
AZN
Astrazeneca
Current Price
$200.73
Runners Also Watch
PFE
Pfizer
28.55
+1.67%
TEVA
Teva Pharma
30.25
+0.43%
NVS
Novartis AG
155.08
+1.53%
MRK
Merck Company
120.84
+0.44%
HCM
HUTCHMED (China) Limited
15.14
+1.20%

AZN Price Performance
$197.52 (+1.63%)
$94.96 (+111.38%)
$83.77 (+139.62%)
$67.05 (+199.37%)
AZN Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Revenue increase YoY
Earnings decline YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Expands stock buyback program
Future
Future
Earnings are forecast to grow
AZN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AZN Street Sentiment is extremely bullish and have positive views on the near-term outlook
AZN has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
AZN Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Expands stock buyback program
AZN Trading Signals
AZN has closed up for 4 consecutive days
AZN showing early bullish trend, price above MA20 (195.35) and MA20 above MA50 (166.84)
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.